DaVita Inks $55 Million Settlement In Epogen FCA Suit

Law360, New York (July 3, 2012, 11:58 AM EDT) -- Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.’s anemia drug Epogen.

The lawsuit was filed in 2002 in the Eastern District of Texas by former Amgen employee Ivey Woodard. He claimed DaVita was administering so-called overfill — an extra quantity of a drug in each vial, required by law to ensure full doses are given — of Epogen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.